Neurotoxicity of Nanomaterials: An Up-to-Date Overview.
| Title: | Neurotoxicity of Nanomaterials: An Up-to-Date Overview. |
|---|---|
| Authors: | Teleanu DM; Emergency University Hospital, Bucharest, Romania, 'Carol Davila' University of Medicine and Pharmacy, Bucharest 050474, Romania. telepapa@hotmail.com.; Chircov C; Faculty of Engineering in Foreign Languages, Politehnica University of Bucharest, București 060042, Romania. cristina.chircov@yahoo.com.; Department of Science and Engineering of Oxide Materials and Nanomaterials, Faculty of Applied Chemistry and Materials Science, Politehnica University of Bucharest, Bucharest 060041, Romania. cristina.chircov@yahoo.com.; Grumezescu AM; Department of Science and Engineering of Oxide Materials and Nanomaterials, Faculty of Applied Chemistry and Materials Science, Politehnica University of Bucharest, Bucharest 060041, Romania. grumezescu@yahoo.com.; ICUB-Research Institute of University of Bucharest, University of Bucharest, 36-46 M. Kogalniceanu Blvd., Bucharest 050107, Romania. grumezescu@yahoo.com.; Teleanu RI; Emergency University Hospital, Bucharest, Romania, 'Carol Davila' University of Medicine and Pharmacy, Bucharest 050474, Romania. raluca.teleanu@umfcd.ro. |
| Source: | Nanomaterials (Basel, Switzerland) [Nanomaterials (Basel)] 2019 Jan 13; Vol. 9 (1). Date of Electronic Publication: 2019 Jan 13. |
| Publication Type: | Journal Article; Review |
| Language: | English |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101610216 Publication Model: Electronic Cited Medium: Print ISSN: 2079-4991 (Print) Linking ISSN: 20794991 NLM ISO Abbreviation: Nanomaterials (Basel) Subsets: PubMed not MEDLINE |
| Imprint Name(s): | Original Publication: Basel, Switzerland : MDPI AG, [2011]- |
| Abstract: | The field of nanotechnology, through which nanomaterials are designed, characterized, produced, and applied, is rapidly emerging in various fields, including energy, electronics, food and agriculture, environmental science, cosmetics, and medicine. The most common biomedical applications of nanomaterials involve drug delivery, bioimaging, and gene and cancer therapy. Since they possess unique properties which are different than bulk materials, toxic effects and long-term impacts on organisms are not completely known. Therefore, the purpose of this review is to emphasize the main neurotoxic effects induced by nanoparticles, liposomes, dendrimers, carbon nanotubes, and quantum dots, as well as the key neurotoxicology assays to evaluate them. |
| References: | Nat Rev Neurosci. 2006 Jan;7(1):65-74. (PMID: 16371951); Biochim Biophys Acta. 2011 Feb;1812(2):275-82. (PMID: 20637864); PLoS One. 2012;7(11):e48752. (PMID: 23152799); J Food Drug Anal. 2014 Mar;22(1):147-160. (PMID: 24673911); J Hazard Mater. 2015;283:480-9. (PMID: 25464286); Regul Toxicol Pharmacol. 2015 Oct;73(1):137-50. (PMID: 26111608); Biochem Biophys Res Commun. 2015 Dec 18;468(3):498-503. (PMID: 26187673); Rom J Morphol Embryol. 2015;56(2):365-70. (PMID: 26193200); PLoS One. 2015 Aug 06;10(8):e0134722. (PMID: 26248340); Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016 Mar-Apr;8(2):271-99. (PMID: 26314803); J Appl Toxicol. 2016 Mar;36(3):345-51. (PMID: 26364743); J Nanopart Res. 2014 Jun 1;16(6):null. (PMID: 26420981); Neurotoxicology. 2016 Jan;52:210-21. (PMID: 26702581); Rom J Morphol Embryol. 2015;56(4):1481-93. (PMID: 26743298); J Invest Dermatol. 2016 Jan;136(1):e1-e7. (PMID: 26763463); Cell Cycle. 2016;15(2):196-212. (PMID: 26825227); Toxicol Appl Pharmacol. 2016 May 15;299:1-2. (PMID: 26908175); Int J Pharm. 2016 Aug 30;510(2):532-42. (PMID: 27032567); J Trace Elem Med Biol. 2016 Dec;38:53-63. (PMID: 27056797); Toxicol Sci. 2016 Jul;152(1):128-44. (PMID: 27125967); J Med Chem. 2016 Sep 22;59(18):8149-67. (PMID: 27142556); J Toxicol Sci. 2016;41(3):351-70. (PMID: 27193728); Toxicol Ind Health. 2017 Apr;33(4):340-350. (PMID: 27230352); Nanoscale Res Lett. 2016 Dec;11(1):291. (PMID: 27295259); Beilstein J Nanotechnol. 2016 Apr 29;7:645-54. (PMID: 27335754); CNS Neurol Disord Drug Targets. 2016;15(10):1306-1324. (PMID: 27488421); J Transl Med. 2017 Jan 23;15(1):18. (PMID: 28114956); Chembiochem. 2017 May 18;18(10):960-964. (PMID: 28224731); Int J Mol Sci. 2017 Mar 14;18(3):. (PMID: 28335421); J Cell Death. 2017 Feb 24;10:1179670717691251. (PMID: 28469473); Oncol Lett. 2017 Jun;13(6):3982-3988. (PMID: 28588692); Curr Med Chem. 2018 Feb 12;25(4):540-555. (PMID: 28618993); BMC Neurosci. 2017 Jun 26;18(1):51. (PMID: 28651647); Prog Neurobiol. 2017 Oct;157:29-48. (PMID: 28743465); Food Chem Toxicol. 2017 Nov;109(Pt 1):797-811. (PMID: 28847762); Mater Sci Eng C Mater Biol Appl. 2017 Nov 1;80:771-784. (PMID: 28866227); Front Med (Lausanne). 2017 Sep 11;4:148. (PMID: 28955710); Nanomedicine (Lond). 2017 Oct;12(20):2453-2470. (PMID: 28972461); Toxicol Appl Pharmacol. 2017 Dec 15;337:1-11. (PMID: 28993268); Prog Neurobiol. 2018 Jan;160:45-63. (PMID: 29108800); Nanomaterials (Basel). 2017 Dec 25;8(1):null. (PMID: 29295581); Vitam Horm. 2018;106:283-312. (PMID: 29407439); Adv Exp Med Biol. 2018;1048:227-250. (PMID: 29453542); Genes Dev. 2018 Apr 1;32(7-8):466-478. (PMID: 29692355); Nanoscale. 2018 Jul 13;10(27):12871-12934. (PMID: 29926865); Part Fibre Toxicol. 2018 Jul 3;15(1):28. (PMID: 29970116); Nanoscale Res Lett. 2018 Aug 10;13(1):231. (PMID: 30097809); Nanomaterials (Basel). 2018 Aug 31;8(9):null. (PMID: 30200373); J Clin Med. 2018 Nov 27;7(12):null. (PMID: 30486404) |
| Contributed Indexing: | Keywords: bioimaging; cancer therapy; drug delivery; gene therapy; nanomaterials; neurotoxicity |
| Entry Date(s): | Date Created: 20190116 Latest Revision: 20201001 |
| Update Code: | 20260130 |
| PubMed Central ID: | PMC6359621 |
| DOI: | 10.3390/nano9010096 |
| PMID: | 30642104 |
| Database: | MEDLINE |
Journal Article; Review